Annual Report

The report highlights PT Enseval Putera Megatrading Tbk's performance in 2024, showcasing a net sales growth of 8.59% to Rp30.96 trillion and an operating profit increase of 10.21% to Rp964.05 billion. The company expanded its product portfolio through collaborations with new principals and established a joint venture, PT Livzon Pharma Indonesia, to manufacture active pharmaceutical ingredients. To support sustainability, Enseval implemented green initiatives such as utilizing solar cells, rainwater harvesting, and gradually increasing its electric motorcycle delivery fleet. Additionally, the company advanced its digital transformation by optimizing its B2B digital order management platform, EMOS, and its integrated logistics platform, MOSTRANS.

Report type

Annual Report with Sustainability Disclosures

Class

Embedded

Scope

Full report

Fiscal year

2024

Publication date

29 April 2025

Language

English, Indonesian

Pages

 

File size

 

GRI

••••••

SASB

••••••

TCFD

••••••

ISSB

••••••

ESRS

••••••

Integrated Reporting Framework

••••••

GHG Protocol

••••••

EU Taxonomy

••••••

CDP

••••••

Assessment

••••••